Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 11/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 11/20 | 0.39 |
| ▸ | DRD2 | P14416 | 6/20 | 0.34 |
| ▸ | DRD4 | P21917 | 6/20 | 0.34 |
| ▸ | DRD3 | P35462 | 6/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31444132 | 0.83 | DDB1 (0.38) | DDB1CRBNDRD4KDM4EALDH1A1 | |
| SCHEMBL31443748 | 0.83 | DDB1 (0.45) | DDB1CRBNDRD2DRD4DRD3 | |
| SCHEMBL31444107 | 0.83 | DDB1 (0.45) | DDB1CRBNDRD2DRD4DRD3 | |
| SCHEMBL31443774 | 0.81 | DDB1 (0.44) | DDB1CRBNALDH1A1 | |
| SCHEMBL31443879 | 0.79 | CRBN (0.40) | DDB1CRBNDRD2DRD4DRD3 | |
| SCHEMBL30678685 | 0.76 | DDB1 (0.58) | DDB1CRBNDRD2DRD3KDM4E | |
| SCHEMBL26112661 | 0.76 | DDB1 (0.58) | DDB1CRBNDRD2DRD3KDM4E | |
| SCHEMBL31443902 | 0.74 | DDB1 (0.38) | DDB1CRBNDRD4KDM4EALDH1A1 | |
| SCHEMBL31444154 | 0.73 | DDB1 (0.45) | DDB1CRBNDRD4 | |
| SCHEMBL31443981 | 0.69 | CRBN (0.58) | DDB1CRBNKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096856-A1 | COVALENT CEREBLON LIGANDS | C4 THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |